Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2171974 | 1.00 | CA2 (0.36) | CA2CA1CA7CA14OR51E2 | |
| SCHEMBL16114175 | 0.86 | OR51E2 (0.40) | CA2OR51E2ALDH1A1TDP1MAPK1 | |
| SCHEMBL31346314 | 0.81 | CA2 (0.37) | CA2CA1CA7CA14MAPT | |
| SCHEMBL1300587 | 0.80 | TSHR (0.44) | CA1TDP1TSHRHAO1 | |
| SCHEMBL23882614 | 0.79 | OR51E2 (0.41) | CA2OR51E2ALDH1A1TDP1MAPK1 | |
| SCHEMBL11328060 | 0.79 | CES1 (0.39) | CA2CA1CA7CA14ELANE | |
| SCHEMBL28248821 | 0.79 | SLC22A6 (0.39) | OR51E2ALDH1A1TDP1MAPK1SLC13A3 | |
| SCHEMBL28248822 | 0.79 | SLC22A6 (0.39) | OR51E2ALDH1A1TDP1MAPK1SLC13A3 | |
| SCHEMBL14672577 | 0.79 | GRIK1 (0.39) | CA2CA1CA7CA14MAPT | |
| SCHEMBL50835 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10450589-B2 | Microbial synthesis of aldehydes and corresponding alcohols | EASEL BIOTECHNOLOGIES, LLC (US) | 2019-10-22 | — | — | US | claimed |
| EP-2686432-B1 | MICROBIAL SYNTHESES OF ALDEHYDES AND CORRESPONDING ALCOHOLS | EASEL BIOTECHNOLOGIES LLC (US) | 2018-12-26 | — | — | EP | claimed |
| US-20170283836-A1 | Microbial Synthesis Of Aldehydes And Corresponding Alcohols | EASEL BIOTECHNOLOGIES, LLC | 2017-10-05 | — | — | US | claimed |
| US-9708631-B2 | Microbial synthesis of aldehydes and corresponding alcohols | EASEL BIOTECHNOLOGIES, LLC (US) | 2017-07-18 | — | — | US | claimed |
| EP-2346991-B1 | PRODUCTION OF C5-C8 ALCOHOLS USING EVOLVED ENZYMES AND METABOLICALLY ENGINEERED MICROORGANISMS | UNIV CALIFORNIA (US) | 2016-12-28 | — | — | EP | claimed |
| US-20160130611-A1 | Microbial Synthesis Of Aldehydes And Corresponding Alcohols | EASEL BIOTECHNOLOGIES, LLC | 2016-05-12 | — | — | US | claimed |
| US-9206443-B2 | Microbial synthesis of aldehydes and corresponding alcohols | EASEL BIOTECHNOLOGIES, LLC (US) | 2015-12-08 | — | — | US | claimed |
| EP-2686432-A2 | MICROBIAL SYNTHESES OF ALDEHYDES AND CORRESPONDING ALCOHOLS | Easel Biotechnologies, LLC (US) | 2014-01-22 | — | — | EP | claimed |
| US-20140011231-A1 | Microbial Synthesis Of Aldehydes And Corresponding Alcohols | EASEL BIOTECHNOLOGIES, LLC (US) | 2014-01-09 | — | — | US | claimed |
| US-8298798-B2 | Production of C5-C8 alcohols using evolved enzymes and metabolically engineered microorganisms | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-10-30 | — | — | US | claimed |
| WO-2012125688-A2 | MICROBIAL SYNTHESES OF ALDEHYDES AND CORRESPONDING ALCOHOLS | EASEL BIOTECHNOLOGIES, LLC (US) | 2012-09-20 | — | — | WO | claimed |
| US-20110201083-A1 | PRODUCTION OF C5-C8 ALCOHOLS USING EVOLVED ENZYMES AND METABOLICALLY ENGINEERED MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-08-18 | — | — | US | claimed |
| EP-2346991-A2 | PRODUCTION OF C5-C8 ALCOHOLS USING EVOLVED ENZYMES AND METABOLICALLY ENGINEERED MICROORGANISMS | The Regents Of The University Of California (US) | 2011-07-27 | — | — | EP | claimed |
| WO-2010045629-A2 | PRODUCTION OF C5-C8 ALCOHOLS USING EVOLVED ENZYMES AND METABOLICALLY ENGINEERED MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-04-22 | — | — | WO | claimed |
| US-5854035-A | Enzyme with leuDH activity, nucleotide sequence coding therefor and process for the prepartion of the enzyme | DEGUSSA AG (DE) | 1998-12-29 | — | — | US | claimed |
| EP-0792933-A2 | Enzyme having LeuDH activity, nucleotide sequence coding therefor and process for the preparation of this enzyme | Degussa Aktiengesellschaft (DE) | 1997-09-03 | — | — | EP | claimed |
| CN-118028837-A | Amino Acid Synthesis Method | 中山大学 | 2024-05-14 | — | — | CN | disclosed |
| US-20210171688-A1 | BIOCOMPATIBLE COPOLYMER, CURABLE COMPOSITION, BIOCOMPATIBLE COATING LAYER AND BIOCOMPATIBLE DEVICE INCLUDING THE SAME | NATIONAL CENTRAL UNIVERSITY (TW) | 2021-06-10 | — | — | US | disclosed |
| US-5854035-A | Enzyme with leuDH activity, nucleotide sequence coding therefor and process for the prepartion of the enzyme | DEGUSSA AG (DE) | 1998-12-29 | — | — | US | disclosed |
| EP-0792933-A2 | Enzyme having LeuDH activity, nucleotide sequence coding therefor and process for the preparation of this enzyme | Degussa Aktiengesellschaft (DE) | 1997-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201083-A1 | PRODUCTION OF C5-C8 ALCOHOLS USING EVOLVED ENZYMES AND METABOLICALLY ENGINEERED MICROORGANISMS | ADH5, ADH1C, ADH1A | CA2 4048/4885CA1 2977/4885CA7 1964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.